MedTrace Logo

Goal-directed Labor Epidural Analgesia Maintenance

NCT05255263 · Status: WITHDRAWN · Phase: NA · Type: INTERVENTIONAL

Last updated 2022-09-14

No results posted yet for this study

Summary

The GLEAM trial is a multicenter, pragmatic, cluster-randomized trial to assess the effects of programmed intermittent epidural bolus versus continuous epidural infusion on the rate of spontaneous vaginal delivery and several other clinically-relevant outcomes.

Conditions

  • Labor Onset and Length Abnormalities

Interventions

OTHER

PIEB

Programmed Intermittent Epidural Bolus with Patient-Controlled Epidural Analgesia

OTHER

CEI

Continuous Epidural Infusion with Patient-Controlled Epidural Analgesia

Sponsors & Collaborators

Principal Investigators

  • Ronald B George, MD · University of California, San Francisco

Study Design

Allocation
RANDOMIZED
Purpose
OTHER
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
FEMALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2022-06-01
Primary Completion
2022-06-01
Completion
2022-06-01

Countries

  • United States

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05255263 on ClinicalTrials.gov